Invera Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$861K Sell
2,208
-1,071
-33% -$453K 0.46% 59
2026
Q1
$1.55M Sell
3,279
-11
-0.3% -$5.54K 1% 33
2025
Q4
$1.54M Sell
3,290
-152
-4% -$70.6K 0.97% 32
2025
Q3
$1.47M Sell
3,442
-20
-0.6% -$7.75K 0.9% 36
2025
Q2
$1.33M Sell
3,462
-72
-2% -$25.9K 0.86% 36
2025
Q1
$1.22M Sell
3,534
-32
-0.9% -$10.3K 0.79% 41
2024
Q4
$1.16M Sell
3,566
-23
-0.6% -$8.04K 1.15% 25
2024
Q3
$1.28M Sell
3,589
-75
-2% -$27.5K 1.27% 25
2024
Q2
$1.16M Buy
3,664
+23
+0.6% +$7.47K 1.19% 26
2024
Q1
$1.08M Sell
3,641
-21
-0.6% -$6.42K 0.92% 36
2023
Q4
$991K Buy
+3,662
New +$905K 0.62% 55

Other funds holding HCA

Invera Wealth Advisors's HCA Position: Q2 2026 in Review

Invera Wealth Advisors reduced its HCA Healthcare (HCA) stake by 33% in Q2 2026, selling an estimated $453K and leaving 2,208 shares worth $861K. The position accounts for 0.46% of the portfolio, ranked #59.

Invera Wealth Advisors first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.55M in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Invera Wealth Advisors held 2,208 shares of HCA Healthcare worth $861K as of Q2 2026.
  • Invera Wealth Advisors sold 1,071 HCA Healthcare shares in Q2 2026, an estimated $453K.
  • HCA Healthcare made up 0.46% of Invera Wealth Advisors's portfolio in Q2 2026, its #59 holding.
  • Invera Wealth Advisors first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Invera Wealth Advisors's HCA Healthcare position peaked at $1.55M in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Invera Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.